GlaxoSmithKline unit joins patent pool for AIDS drugs

A GlaxoSmithKline logo is seen outside one of its buildings in west London, ahead of company resultsLONDON (Reuters) – GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries. ViiV Healthcare, majority-owned by GSK, is the second research-based pharmaceutical business to sign up to the new Medicines Patent Pool, following a lead set in 2011 by Gilead Sciences. Although more than half of people living with the human immunodeficiency virus (HIV) that causes AIDS now get the drugs they need – thanks to a major roll-out of treatment in Africa – an estimated 6. …



Sexual Health News Headlines – Yahoo! News